Immunotherapy Combined With Y-90 and SBRT for Colorectal Liver Metastases

Condition:   Colorectal Cancer Interventions:   Drug: Durvalumab;   Drug: Durvalumab and Tremelimumab;   Drug: Y-90 Selective Internal Radiation Therapy (SIRT);   Drug: Stereotactic Body Radiation Therapy (SBRT) Sponsors:   University of Colorado, Denver;   AstraZeneca Not yet recruiting

Source: ClinicalTrials.gov - January 14, 2019 Category: Research Source Type: clinical trials